Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Annemans

Showing results (31-40 of 261) with videos related to

Pageof 27
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|May 10, 2012
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsGraham F Pineo, Jay Lin, Lieven Annemans
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Differential pricing of new pharmaceuticals in lower income European countriesZoltán Kaló, Lieven Annemans, Louis P Garrison
Journal of Clinical Lipidology|August 21, 2019
PCSK9 inhibition, atherosclerotic cardiovascular disease, and health economics: Challenges at the crossroadsLieven Annemans, Jane K Stock, M John Chapman
BMC Health Services Research|March 28, 2023
Physicians' views on optimal use and payment system for telemedicine: a qualitative studySarah Raes, Lieven Annemans, Ruben Willems, et al.
Pharmacoeconomics|September 22, 2005
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos, Maarten J Postma, Lieven Annemans
Orthopaedics & Traumatology, Surgery & Research : OTSR|May 16, 2020
Do custom 3D-printed revision acetabular implants provide enough value to justify the additional costs? The health-economic comparison of a new porous 3D-printed hip implant for revision arthroplasty of Paprosky type 3B acetabular defects and its closest alternativePhilip Tack, Jan Victor, Paul Gemmel, et al.
Pharmacoeconomics|February 8, 2006
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular diseaseMark Lamotte, Lieven Annemans, Thomas Evers, et al.
Biomedical Engineering Online|October 23, 2016
3D-printing techniques in a medical setting: a systematic literature reviewPhilip Tack, Jan Victor, Paul Gemmel, et al.
BMC Health Services Research|May 12, 2018
Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on severity of illnessSarah Dewilde, Lieven Annemans, Hilde Pincé, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 15, 2012
Changes to the statin prescribing policy in Belgium: potential impact in clinical and economic termsDanny Liew, Kate Webb, Sophie Marbaix, et al.
Pageof 27

Showing results (31-40 of 261) with videos related to

Sort By:
Pageof 27
Clinicoeconomics and Outcomes Research : CEOR|May 10, 2012
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsGraham F Pineo, Jay Lin, Lieven Annemans
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Differential pricing of new pharmaceuticals in lower income European countriesZoltán Kaló, Lieven Annemans, Louis P Garrison
Journal of Clinical Lipidology|August 21, 2019
PCSK9 inhibition, atherosclerotic cardiovascular disease, and health economics: Challenges at the crossroadsLieven Annemans, Jane K Stock, M John Chapman
BMC Health Services Research|March 28, 2023
Physicians' views on optimal use and payment system for telemedicine: a qualitative studySarah Raes, Lieven Annemans, Ruben Willems, et al.
Pharmacoeconomics|September 22, 2005
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos, Maarten J Postma, Lieven Annemans
Orthopaedics & Traumatology, Surgery & Research : OTSR|May 16, 2020
Do custom 3D-printed revision acetabular implants provide enough value to justify the additional costs? The health-economic comparison of a new porous 3D-printed hip implant for revision arthroplasty of Paprosky type 3B acetabular defects and its closest alternativePhilip Tack, Jan Victor, Paul Gemmel, et al.
Pharmacoeconomics|February 8, 2006
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular diseaseMark Lamotte, Lieven Annemans, Thomas Evers, et al.
Biomedical Engineering Online|October 23, 2016
3D-printing techniques in a medical setting: a systematic literature reviewPhilip Tack, Jan Victor, Paul Gemmel, et al.
BMC Health Services Research|May 12, 2018
Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on severity of illnessSarah Dewilde, Lieven Annemans, Hilde Pincé, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 15, 2012
Changes to the statin prescribing policy in Belgium: potential impact in clinical and economic termsDanny Liew, Kate Webb, Sophie Marbaix, et al.
Pageof 27